| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,344,713 | 2,688,656 | 3,064,688 | 3,346,752 | | Cost of Revenue | 1,908,607 | 2,121,450 | 2,337,222 | 2,575,422 | | | Gross Profit | 436,106 | 567,206 | 727,466 | 771,330 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 306,191 | 348,984 | 332,683 | 373,138 | | Non Recurring |
-
|
-
|
-
| (3,396) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 129,915 | 218,222 | 394,783 | 401,588 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (38,987) | 9,958 | (9,958) | (21,751) | | Earnings Before Interest And Taxes | 90,928 | 228,180 | 384,825 | 379,837 | | Interest Expense | 28,393 | 30,307 | 28,096 | 25,019 | | Income Before Tax | 62,535 | 197,873 | 356,729 | 354,818 | | Income Tax Expense | 9,113 | 42,472 | 106,553 | 102,253 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 53,422 | 155,401 | 250,176 | 252,565 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 53,422 | 155,401 | 250,176 | 252,565 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $53,422 | $155,401 | $250,176 | $252,565 |
|
0.45% Nasdaq 
0.20%
Income Statement
